Dianthus Therapeutics, Inc. DNTH

88.55 (2.16) (2.38%) as of 25 Sep
Market cap
$5.1B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
886.81 1,111.26 404.30 402.61

+8 more quarters

Receivables
0.11 1.23 0.05 5.00
Total current assets
897.54 1,119.91 409.44 413.83
Property, Plant, Equpment (Net)
0.42 0.27 0.30 0.19
Long-Term Investments
303.63 113.87 110.14 152.87
Long-term assets (Other)
10.46 11.54 9.72 9.26
Total non-current assets
315.73 126.97 121.48 163.62
Total Assets
1,213.27 1,246.88 530.92 577.45
Accounts Payable
6.39 5.27 9.73 6.71
Accrued Expenses
26.10 31.13 19.45 15.98
Current Revenue (Deferred)
1.52 1.49 1.19 0.95
Total current liabilities
34.39 38.28 30.73 23.86
Non-current Revenue (Deferred)
5.94 6.32 5.77 6.07
Non-current Liabilities (Other)
— — — 1.07
Total non-current liabilities
6.86 7.29 6.79 7.14
Total liabilities
41.25 45.57 37.52 30.99
Additional Paid In Capital
1,601.88 1,579.40 829.60 818.55
Common Stock (Net)
0.06 0.05 0.04 0.04
Retained Earnings
(427.78) (377.56) (336.73) (272.30)
Common Equity (Total)
1,172.03 1,201.31 493.40 546.45
Shareholders Equity (Total)
1,172.03 1,201.31 493.40 546.45
Shareholders Equity and Liabilities (Total)
1,213.27 1,246.88 530.92 577.45
Shares (Common)
54.80 54.58 43.22 42.86
Shareholders Equity (Tangible)
1,172.03 1,201.31 493.40 546.45
Net Debt
(886.81) (1,111.26) (404.29) (402.61)

Fold the line items

In millions of $ except per-share values · columns are period end dates